| Bioactivity | Anticancer agent 238 (compound 5) is an anticancer agent with a notably strong binding affinity towards the CDK-5 enzyme. Anticancer agent 238 shows a strong efficacy agains HCT116 and MCF7 cells, with IC50 values of 13.46 µM and 16.43 µM, respectively[1]. |
| Formula | C17H11ClN4O |
| Molar Mass | 322.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eman A E El-Helw, et al. Synthesis and in silico studies of certain benzo[f]quinoline-based heterocycles as antitumor agents. Sci Rep. 2024 Jul 5;14(1):15522. |
Anticancer agent 238
CAS: F: C17H11ClN4O W: 322.75
Anticancer agent 238 (compound 5) is an anticancer agent with a notably strong binding affinity towards the CDK-5 enzyme
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.